CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- 4 Grant or award Director acquired 12,700 shares (grant or award)
- 4 Planned sale Director sold 9,670 shares at $8.81 ($85,193)
- 4 Grant or award Director acquired 12,700 shares (grant or award)
- 4 Grant or award Director acquired 12,700 shares (grant or award)
- 4 Planned sale Director sold 4,872 shares at $8.75 ($42,630)
- 4 Planned sale Director sold 1,127 shares at $8.75 ($9,861)
- 4 Planned sale Director sold 30,000 shares at $6.95 ($208,500)
- 4 Planned sale Director sold 10,500 shares at $9.77 ($102,575)
- 4 Planned sale President and CEO sold 169,025 shares at $9.57 ($1,617,569)
- 4 Option exercise Director acquired 266,402 shares (option exercise)
- 4 Option exercise See Remarks acquired 91,754 shares (option exercise)
- 4 Grant or award Chief Financial Officer acquired 42,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 121,000 shares (grant or award)
- 4 Grant or award See Remarks acquired 25,000 shares (grant or award)
- 4 Grant or award See Remarks acquired 37,000 shares (grant or award)
- 4 Option exercise See Remarks acquired 46,000 shares (option exercise)
- 4 Planned sale President and CEO sold 50,000 shares at $15.00 ($750,000)
- 4 Planned sale President and CEO sold 51,234 shares at $14.32 ($733,671)
- 4 Planned sale See Remarks sold 36,000 shares at $16.00 ($576,000)
- 4 Planned sale See Remarks sold 208,836 shares at an average $13.67 ($2,855,051)
Page 3 of 14 · 274 filings